Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer

Oncology Reports

Volumn 30, Issue 6, 2013, Pages 2929-2936

  Phueaouan, Thanong ^a   Chaiyawat, Parunya ^a   Netsirisawan, Pukkavadee ^a   Chokchaichamnankit, Daranee ^b   Punyarit, Phaibul ^c   Srisomsap, Chantragan ^b   Svasti, Jisnuson ^a,b   Champattanachai, Voraratt ^a,b  

^a Research and Innovation   (Thailand)

^b Krung Thep Maha Nakhon   (Thailand)

^c Army Institute of Pathology   (Thailand)

Author keywords

Annexin A2; Colorectal cancer; Hexosamine biosynthesis pathway; O GlcNAcylation

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALPHA TUBULIN; CARBONATE DEHYDRATASE I; CREATINE KINASE; CREATINE KINASE B; CYTOKERATIN 18; DJ 1 PROTEIN; ENZYME; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); HEAT SHOCK PROTEIN 70; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K; LAMININ BINDING PROTEIN; LIPOCORTIN 2; O GLCNAC TRANSFERASE; O GLCNACASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SELENIUM BINDING PROTEIN; SELENIUM BINDING PROTEIN 1; SYNEXIN; UNCLASSIFIED DRUG;

ACYLATION; ARTICLE; CANCER GRADING; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; TANDEM MASS SPECTROMETRY;

ACETYLGLUCOSAMINE; BETA-N-ACETYLHEXOSAMINIDASES; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; HEXOSAMINES; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASM PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TANDEM MASS SPECTROMETRY;

EID: 84892396362     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2794     Document Type: Article

References (41)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Attasara P: Hospital-Based Cancer Registry 2010. National Cancer Institute in Thailand, Bangkok, 2011.
3. Siegel RL, Jemal A and Ward EM: Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 18: 1695-1698, 2009.
4. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S and Couture J: Molecular biology of colorectal cancer. Curr Probl Cancer 21: 233-300, 1997.
5. Gillies RJ, Robey I and Gatenby RA: Causes and consequences of increased glucose metabolism of cancers. J Nucl Med 49 (Suppl 2): S24-S42, 2008.
6. Chowdhury FU, Shah N, Scarsbrook AF and Bradley KM: (18F)FDG PET/CT imaging of colorectal cancer: a pictorial review. Postgrad Med J 86: 174-182, 2010.
7. Marshall S, Bacote V and Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266: 4706-4712, 1991.
8. Kreppel LK, Blomberg MA and Hart GW: Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopep tide repeats. J Biol Chem 272: 9308-9315, 1997.
9. Gao Y, Wells L, Comer FI, Parker GJ and Hart GW: Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic â -N-acetylglucosaminidase from human brain. J Biol Chem 276: 9838-9845, 2001.
10. Hart GW, Slawson C, Ramirez-Correa G and Lagerlof O: Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem 80: 825-858, 2011.
11. Mi W, Gu Y, Han C, et al: O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy. Biochim Biophys Acta 1812: 514-519, 2011.
12. Gu Y, Mi W, Ge Y, et al: GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res 70: 6344-6351, 2010.
13. Champattanachai V, Netsirisawan P, Chaiyawat P, et al : Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer. Proteomics 13: 2088-2099, 2013.
14. Pham VC, Henzel WJ and Lill JR: Rapid on-membrane proteo lytic cleavage for Edman sequencing and mass spectrometric identification of proteins. Electrophoresis 26: 4243-4251, 2005.
15. Zhu Q, Zhou L, Yang Z, et al: O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Med Oncol 29: 985-993, 2012.
16. Lynch TP, Ferrer CM, Jackson SR, Shahriari KS, Vosseller K and Reginato MJ: Critical role of O-Linkedß- N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem 287: 11070-11081, 2012.
17. Yehezkel G, Cohen L, Kliger A, Manor E and Khalaila I: O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-β-D-glucosaminidase silencing on cell phenotype and transcriptome. J Biol Chem 287: 28755-28769, 2012.
18. Gerke V and Moss SE: Annexins: from structure to function. Physiol Rev 82: 331-371, 2002.
19. 2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6: 449-461, 2005.
20. Duncan R, Carpenter B, Main LC, Telfer C and Murray GI: Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98: 426-433, 2008.
21. Hsu PI, Huang MS, Chen HC, et al: The significance of ANXA7 expression and its correlation with poor cellular differentiation and enhanced metastatic potential of gastric cancer. J Surg Oncol 97: 609-614, 2008.
22. Ku NO and Omary MB: Identification and mutational analysis of the glycosylation sites of human keratin 18. J Biol Chem 270: 11820-11827, 1995.
23. Srikanth B, Vaidya MM and Kalraiya RD: O-GlcNAcylation determines the solubility, filament organization, and stability of keratins 8 and 18. J Biol Chem 285: 34062-34071, 2010.
24. Ku NO, Toivola DM, Strnad P and Omary MB: Cytoskeletal keratin glycosylation protects epithelial tissue from injury. Nat Cell Biol 12: 876-885, 2010.
25. Walgren JL, Vincent TS, Schey KL and Buse MG: High glucose and insulin promote O-GlcNAc modification of proteins, including β-tubulin. Am J Physiol Endocrinol Metab 284: E424-E434, 2003.
26. Ji S, Kang JG, Park SY, Lee J, Oh YJ and Cho JW: O-GlcNAcylation of tubulin inhibits its polymerization. Amino Acids 40: 809-818, 2011.
27. Krecic AM and Swanson MS: hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11: 363-371, 1999.
28. Martinez-Contreras R, Cloutier P, Shkreta L, Fisette JF, Revil T and Chabot B: hnRNP proteins and splicing control. Adv Exp Med Biol 623: 123-147, 2007.
29. Boukakis G, Patrinou-Georgoula M, Lekarakou M, Valavanis C and Guialis A: Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues. BMC Cancer 10: 434, 2010.
30. Fielding P, Turnbull L, Prime W, Walshaw M and Field JK: Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens: a clinical marker of early lung cancer detection. Clin Cancer Res 5: 4048-4052, 1999.
31. Garneau D, Revil T, Fisette JF and Chabot B: Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alterna tive splicing of the apoptotic mediator Bcl-x. J Biol Chem 280: 22641-22650, 2005.
32. Hope NR and Murray GI: The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relation ship of heterogeneous nuclear ribonucleoproteins with prognosis. Hum Pathol 42: 393-402, 2011.
33. Wang Z, Pandey A and Hart GW: Dynamic interplay between O-linked N -acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation. Mol Cell Proteomics 6: 1365-1379, 2007.
34. Gauczynski S, Peyrin JM, Haïk S, et al: The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20: 5863-5875, 2001.
35. Wells L, Vosseller K, Cole RN, Cronshaw JM, Matunis MJ and Hart GW: Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications. Mol Cell Proteomics 1: 791-804, 2002.
36. Lefebvre T, Cieniewski C, Lemoine J, et al: Identification of N-acetyl-D-glucosamine-specific lectins from rat liver cytosolic and nuclear compartments as heat-shock proteins. Biochem J 360: 179-188, 2001.
37. Drummond FJ, Sowden J, Morrison K and Edwards YH: Colon carbonic anhydrase 1: transactivation of gene expression by the homeodomain protein Cdx2. FEBS Lett 423: 218-222, 1998.
38. Parkkila S, Rajaniemi H, Parkkila AK, et al: Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci USA 97: 2220-2224, 2000.
39. Zarghami N, Giai M, Yu H, et al: Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients. Br J Cancer 73: 386-390, 1996.
40. Li T, Yang W, Li M, et al: Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res 52: 1289-1299, 2008.
41. Kim H, Kang HJ, You KT, et al: Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 6: 3466-3476, 2006.